
The package of measures includes creating the equivalent of 7,000 additional hospital beds NHS England has announced a package …

The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …

Medical centres in the US have started referring older patients with long COVID-19-related symptoms for cognitive rehabilitation in order to …

Radioligand therapy is used to treat patients with advanced prostate cancer

BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials

The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …

The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.
Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to …

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given …

The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At …
Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area …

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …

A doctor in New York State has warned that there could be hundreds, or even thousands, of undiagnosed cases of …
The FDA has approved MYFEMBREE as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with …

The SMC has accepted the first licensed treatment for adults with newly diagnosed systemic light chain (AL) amyloidosis. Darzalex® (daratumumab) …

A consensus group of leading experts have shared that the NHS should offer all cancer patients genetic profiling of their …

HUTCHMED has announced that its global Phase III FRESCO-2 trial, evaluating the investigational use of fruquintinib, reached its primary endpoint …